A large-scale genetic association study to evaluate the contribution of Omi/HtrA2 (PARK13) to Parkinson's disease

Neurobiology of Aging

Volumn 32, Issue 3, 2011, Pages 548.e9-548.e18

  Krüger, Rejko ^a   Sharma, Manu ^a   Riess, Olaf ^a   Gasser, Thomas ^b   Van Broeckhoven, Christine ^b   Theuns, Jessie ^c   Aasly, Jan ^d   Annesi, Grazia ^e   Bentivoglio, Anna Rita ^f,g,h,i   Brice, Alexis ^j   Djarmati, Ana ^f,g   Elbaz, Alexis ^k   Farrer, Matthew ^l   Ferrarese, Carlo ^m,n   Gibson, J Mark ^o   Hadjigeorgiou, Georgios M ^p   Hattori, Nobutaka ^q   Ioannidis, John P A ^r   Jasinska Myga, Barbara ^s   Klein, Christine ^j   Lambert, Jean Charles ^g   Lesage, Suzanne ^f,g,h,i   Lin, Juei Jueng ^t   Lynch, Timothy ^m,n   Mellick, George D ^u,v   de Nigris, Francesa ^e   Opala, Grzegorz ^s   Prigione, Alessandro ^l   Quattrone, Aldo ^w   Ross, Owen A ^k   Satake, Wataru ^x   Silburn, Peter A ^u,v   Tan, Eng King ^y   Toda, Tatsushi ^x   Tomiyama, Hiroyuki ^q,r   Wirdefeldt, Karin ^z   Wszolek, Zbigniew ^aa   Xiromerisiou, Georgia ^o,p   Maraganore, Demetrius M ^k   more..

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF ANTWERP   (Belgium)

^c NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^d INSTITUTE OF NEUROLOGICAL SCIENCES   (Italy)

^e CATHOLIC UNIVERSITY   (Italy)

^f SORBONNE UNIVERSITÉ   (France)

^g INSERM   (France)

^h INSTITUT DU CERVEAU ET DE LA MOELLE ÉPINIÈRE   (France)

ⁱ PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^j UNIVERSITY OF LÜBECK   (Germany)

^k MAYO CLINIC   (United States)

^l UNIVERSITY OF MILANO BICOCCA   (Italy)

^m MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

ⁿ ROYAL VICTORIA HOSPITAL   (United Kingdom)

^o UNIVERSITY OF THESSALY   (Greece)

^p INSTITUTE OF HUMAN PERFORMANCE AND REHABILITATION   (Greece)

^q JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^r UNIVERSITY OF IOANNINA   (Greece)

^s MEDICAL UNIVERSITY OF SILESIA   (Poland)

^t Chu Shang Show Chwan Hospital   (Taiwan)

^u GRIFFITH UNIVERSITY   (Australia)

^v UNIVERSITY OF QUEENSLAND   (Australia)

^w UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^x KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^y SINGAPORE GENERAL HOSPITAL   (Singapore)

^z KAROLINSKA INSTITUTE   (Sweden)

^aa MAYO CLINIC   (United States)

more..

Author keywords

Genetics; HtrA2; Omi; PARK13; Parkinson's disease

Indexed keywords

SERINE PROTEINASE OMI;

ADULT; AGE; ARTICLE; BAYES THEOREM; CONTROLLED STUDY; DISEASE PREDISPOSITION; ETHNICITY; FAMILY HISTORY; FEMALE; GENDER; GENE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; OMI/HTRA2 GENE; ONSET AGE; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN VARIANT; RISK ASSESSMENT; SCANDINAVIA;

EID: 79952900158     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2009.11.021     Document Type: Article

References (26)

1. Bogaerts V., Nuytemans K., Reumers J., Pals P., Engelborghs S., Pickut B., Corsmit E., Peeters K., Schymkowitz J., De Deyn P.P., Cras P., Rousseau F., Theuns J., Van Broeckhoven C. Genetic variability in the mitochondrial serine protease HTRA2 contributes to risk for Parkinson disease. Hum. Mutat. 2008, 29(6):832-840.
2. Bonifati V., Rizzu P., van Baren M.J., Schaap O., Breedveld G.J., Krieger E., Dekker M.C., Squitieri F., Ibanez P., Joosse M., van Dongen J.W., Vanacore N., van Swieten J.C., Brice A., Meco G., van Duijn C.M., Oostra B.A., Heutink P. Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 2003, 299(5604):256-259.
3. Chanock S.J., Manolio T., Boehnke M., Boerwinkle E., Hunter D.J., Thomas G., Hirschhorn J.N., Abecasis G., Altshuler D., Bailey-Wilson J.E., Brooks L.D., Cardon L.R., Daly M., Donnelly P., Fraumeni J.F., Freimer N.B., Gerhard D.S., Gunter C., Guttmacher A.E., Guyer M.S., Harris E.L., Hoh J., Hoover R., Kong C.A., Merikangas K.R., Morton C.C., Palmer L.J., Phimister E.G., Rice J.P., Roberts J., Rotimi C., Tucker M.A., Vogan K.J., Wacholder S., Wijsman E.M., Winn D.M., Collins F.S. Replicating genotype-phenotype associations. Nature 2007, 447(7145):655-660.
4. de Bakker P.I., Yelensky R., Pe'er I., Gabriel S.B., Daly M.J., Altshuler D. Efficiency and power in genetic association studies. Nat. Genet. 2005, 37(11):1217-1223.
5. Elbaz A., Nelson L.M., Payami H., Ioannidis J.P., Fiske B.K., Annesi G., Carmine Belin A., Factor S.A., Ferrarese C., Hadjigeorgiou G.M., Higgins D.S., Kawakami H., Kruger R., Marder K.S., Mayeux R.P., Mellick G.D., Nutt J.G., Ritz B., Samii A., Tanner C.M., Van Broeckhoven C., Van Den Eeden S.K., Wirdefeldt K., Zabetian C.P., Dehem M., Montimurro J.S., Southwick A., Myers R.M., Trikalinos T.A. Lack of replication of thirteen single-nucleotide polymorphisms implicated in Parkinson's disease: a large-scale international study. Lancet Neurol. 2006, 5(11):917-923.
6. Evangelou E., Maraganore D.M., Annesi G., Brighina L., Brice A., Elbaz A., Ferrarese C., Hadjigeorgiou G.M., Krueger R., Lambert J.C., Lesage S., Markopoulou K., Mellick G.D., Meeus B., Pedersen N.L., Quattrone A., Van Broeckhoven C., Sharma M., Silburn P.A., Tan E.K., Wirdefeldt K., Ioannidis J.P. Non-replication of association for six polymorphisms from meta-analysis of genome-wide association studies of Parkinson's disease: Large-scale collaborative study. Am. J. Med. Genet. B: Neuropsychiatr. Genet. 2009.
7. Fung H.C., Scholz S., Matarin M., Simon-Sanchez J., Hernandez D., Britton A., Gibbs J.R., Langefeld C., Stiegert M.L., Schymick J., Okun M.S., Mandel R.J., Fernandez H.H., Foote K.D., Rodriguez R.L., Peckham E., De Vrieze F.W., Gwinn-Hardy K., Hardy J.A., Singleton A. Genome-wide genotyping in Parkinson's disease and neurologically normal controls: first stage analysis and public release of data. Lancet Neurol. 2006, 5(11):911-916.
8. Inagaki R., Tagawa K., Qi M.L., Enokido Y., Ito H., Tamura T., Shimizu S., Oyanagi K., Arai N., Kanazawa I., Wanker E.E., Okazawa H. Omi/HtrA2 is relevant to the selective vulnerability of striatal neurons in Huntington's disease. Eur. J. Neurosci. 2008, 28(1):30-40.
9. Ioannidis J.P. Calibration of credibility of agnostic genome-wide associations. Am. J. Med. Genet. B: Neuropsychiatr. Genet. 2008, 147B(6):964-972.
10. Ioannidis J.P., Patsopoulos N.A., Evangelou E. Uncertainty in heterogeneity estimates in meta-analyses. BMJ (Clin. Res. ed.) 2007, 335(7626):914-916.
11. Ioannidis J.P., Thomas G., Daly M.J. Validating, augmenting and refining genome-wide association signals. Nat. Rev. 2009, 10(5):318-329.
12. Jones J.M., Datta P., Srinivasula S.M., Ji W., Gupta S., Zhang Z., Davies E., Hajnoczky G., Saunders T.L., Van Keuren M.L., Fernandes-Alnemri T., Meisler M.H., Alnemri E.S. Loss of Omi mitochondrial protease activity causes the neuromuscular disorder of mnd2 mutant mice. Nature 2003, 425(6959):721-727.
13. Kawamoto Y., Kobayashi Y., Suzuki Y., Inoue H., Tomimoto H., Akiguchi I., Budka H., Martins L.M., Downward J., Takahashi R. Accumulation of HtrA2/Omi in neuronal and glial inclusions in brains with alpha-synucleinopathies. J. Neuropathol. Exp. Neurol. 2008, 67(10):984-993.
14. Kitada T., Asakawa S., Hattori N., Matsumine H., Yamamura Y., Minoshima S., Yokochi M., Mizuno Y., Shimizu N. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 1998, 392(6676):605-608.
15. Little J., Higgins J.P., Ioannidis J.P., Moher D., Gagnon F., von Elm E., Khoury M.J., Cohen B., Davey-Smith G., Grimshaw J., Scheet P., Gwinn M., Williamson R.E., Zou G.Y., Hutchings K., Johnson C.Y., Tait V., Wiens M., Golding J., van Duijn C., McLaughlin J., Paterson A., Wells G., Fortier I., Freedman M., Zecevic M., King R., Infante-Rivard C., Stewart A., Birkett N. Strengthening the reporting of genetic association studies (STREGA)-an extension of the STROBE statement. Eur. J. Clin. Investig. 2009, 39(4):247-266.
16. Maraganore D.M., de Andrade M., Elbaz A., Farrer M.J., Ioannidis J.P., Kruger R., Rocca W.A., Schneider N.K., Lesnick T.G., Lincoln S.J., Hulihan M.M., Aasly J.O., Ashizawa T., Chartier-Harlin M.C., Checkoway H., Ferrarese C., Hadjigeorgiou G., Hattori N., Kawakami H., Lambert J.C., Lynch T., Mellick G.D., Papapetropoulos S., Parsian A., Quattrone A., Riess O., Tan E.K., Van Broeckhoven C. Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease. JAMA 2006, 296(6):661-670.
17. Maraganore D.M., de Andrade M., Lesnick T.G., Strain K.J., Farrer M.J., Rocca W.A., Pant P.V., Frazer K.A., Cox D.R., Ballinger D.G. High-resolution whole-genome association study of Parkinson disease. Am. J. Hum. Genet. 2005, 77(5):685-693.
18. McCarthy M.I., Abecasis G.R., Cardon L.R., Goldstein D.B., Little J., Ioannidis J.P., Hirschhorn J.N. Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat. Rev. 2008, 9(5):356-369.
19. Novembre J., Johnson T., Bryc K., Kutalik Z., Boyko A.R., Auton A., Indap A., King K.S., Bergmann S., Nelson M.R., Stephens M., Bustamante C.D. Genes mirror geography within Europe. Nature 2008, 456(7218):98-101.
20. Pankratz N., Wilk J.B., Latourelle J.C., DeStefano A.L., Halter C., Pugh E.W., Doheny K.F., Gusella J.F., Nichols W.C., Foroud T., Myers R.H. Genomewide association study for susceptibility genes contributing to familial Parkinson disease. Hum. Genet. 2009, 124(6):593-605.
21. Ross O.A., Soto A.I., Vilarino-Guell C., Heckman M.G., Diehl N.N., Hulihan M.M., Aasly J.O., Sando S., Gibson J.M., Lynch T., Krygowska-Wajs A., Opala G., Barcikowska M., Czyzewski K., Uitti R.J., Wszolek Z.K., Farrer M.J. Genetic variation of Omi/HtrA2 and Parkinson's disease. Parkinsonism Relat. Disorders 2008, 14(7):539-543.
22. Simon-Sanchez J., Singleton A.B. Sequencing analysis of OMI/HTRA2 shows previously reported pathogenic mutations in neurologically normal controls. Hum. Mol. Genet. 2008, 17(13):1988-1993.
23. Strauss K.M., Martins L.M., Plun-Favreau H., Marx F.P., Kautzmann S., Berg D., Gasser T., Wszolek Z., Muller T., Bornemann A., Wolburg H., Downward J., Riess O., Schulz J.B., Kruger R. Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease. Hum. Mol. Genet. 2005, 14(15):2099-2111.
24. Valente E.M., Salvi S., Ialongo T., Marongiu R., Elia A.E., Caputo V., Romito L., Albanese A., Dallapiccola B., Bentivoglio A.R. PINK1 mutations are associated with sporadic early-onset parkinsonism. Ann. Neurol. 2004, 56(3):336-341.
25. Zondervan K.T., Cardon L.R. The complex interplay among factors that influence allelic association. Nat. Rev. 2004, 5(2):89-100.
26. Zondervan K.T., Cardon L.R. Designing candidate gene and genome-wide case-control association studies. Nat. Protoc. 2007, 2(10):2492-2501.